[{"Assets_0_Q2_USD":918033000.0,"CommonStockSharesOutstanding_0_Q2_shares":254513522.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-137031000.0,"NetIncomeLoss_1_Q2_USD":-84551000.0,"NetIncomeLoss_2_Q2_USD":-204850000.0,"StockholdersEquity_0_Q2_USD":600058000.0,"Ticker":"FOLD","CIK":"1178879","name":"AMICUS THERAPEUTICS, INC.","OfficialName":"Amicus Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2296240629.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190808"}]